Overview
Underlying Asset
| AMGEN INC (AMGN) |
| BRISTOL-MYERS SQUIBB CO (BMY) |
Summary Details
| Initial Price of Note | 100.00 % of par |
| Trade Date | 25-Jun-26 |
| Issue Date | 30-Jun-26 |
| Valuation Date | 25-Jun-29 |
| Maturity Date | 28-Jun-29 |
| Term | 3 years |
| Denomination | USD |
| CUSIP | 78017U5T3 |
| Classification | Growth |
| Structure | Return |
| Protection Type | Barrier |
| Barrier Level | 60 % of the initial level |
| Leverage Factor | 150 % |
| Downside Leverage Factor | 1:1 |
The materials and information on this page are for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy the relevant Notes
Historical Indicative Secondary Market Prices
Benchmarks
Historical Secondary Market Pricing *
| Day Over Day Price Change | - | |
| 52 Week High | () | |
| 52 Week Low | () | |
Performance of Underlying Assets
| Underlying Asset | Ticker | Weight |
Initial Level as of 25-Jun-26 |
Current Index Level |
Barrier |
Barrier Level |
Weighted Component Change |
|---|---|---|---|---|---|---|---|
| AMGEN INC | AMGN | - |
- |
345.60 |
60.00% |
- |
- |
| BRISTOL-MYERS SQUIBB CO | BMY | - |
- |
56.60 |
60.00% |
- |
- |
| Current Performance of the Underlying Assets | 0% |
||||||
| Current Performance of the Underlying Assets, with Leverage applied | 0.00% |
||||||
* For informational purposes only. Whether a Booster will be paid will depend only on the level of the Underlying Asset at maturity.
The materials and information on this page are for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy the relevant Notes